Study compared SGLT2 inhibitors with GLP-1 agonists and DPP-4 inhibitors One class of glucose-lowering agent may help lower the risk of kidney stones in adults with type 2 diabetes, a cohort study suggested. Adults who newly started on an SGLT2 inhibitor had a 31% lower risk of nephrolithiasis compared with those starting on a GLP-1 […]
Read more of this post
No comments:
Post a Comment